F-star Biotechnology Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:F-star Biotechnology Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10910
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mAb2 bispecific monoclonal antibodies; fcab, a new binding region within an antibody; and others. F-star develops drugs intended for the treatment of immune-oncology, breast and gastric cancer indications. The company also offers discovery of antibodies which are selected for their potential to transform the treatment of cancer. It operates in the UK and Austria. F-star is headquartered in Cambridge, Cambridgeshire, the UK.

F-star Biotechnology Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
F-Star Alpha Raises US$13 Million In Series A Financing 10
Partnerships 12
F-star Biotech Enters into Partnership with Merck 12
F-star Enters into Agreement with University of Natural Resources and Life Sciences 13
Licensing Agreements 14
Denali Therapeutics Expands Licensing And Collaboration Agreement with F-star 14
F-star Beta Enters into Licensing Agreement with F-star Biotech 16
F-star Alpha Enters into Licensing Agreement with F-star Biotech 17
F-star Biotech Enters into Licensing Agreement with Genedata 18
F-star Bio Enters into Licensing agreement with AbbVie 19
Acquisition 20
Denali Therapeutics to Acquire F-star Gamma 20
F-star Biotechnology Ltd – Key Competitors 21
F-star Biotechnology Ltd – Key Employees 22
F-star Biotechnology Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Oct 15, 2018: F-star appoints Dr Eliot Forster as Chief Executive Officer 24
Sep 10, 2018: F-star appoints Nessan Bermingham as Chairman of its Board of Directors 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Key Facts 2
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
F-star Biotechnology Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
F-Star Alpha Raises US$13 Million In Series A Financing 10
F-star Biotech Enters into Partnership with Merck 12
F-star Enters into Agreement with University of Natural Resources and Life Sciences 13
Denali Therapeutics Expands Licensing And Collaboration Agreement with F-star 14
F-star Beta Enters into Licensing Agreement with F-star Biotech 16
F-star Alpha Enters into Licensing Agreement with F-star Biotech 17
F-star Biotech Enters into Licensing Agreement with Genedata 18
F-star Bio Enters into Licensing agreement with AbbVie 19
Denali Therapeutics to Acquire F-star Gamma 20
F-star Biotechnology Ltd, Key Competitors 21
F-star Biotechnology Ltd, Key Employees 22
F-star Biotechnology Ltd, Subsidiaries 23

List of Figures
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
F-star Biotechnology Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[F-star Biotechnology Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hikma Pharmaceuticals PLC:企業のM&A・事業提携・投資動向
    Hikma Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hikma Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Valiant Holding AG:企業の戦略・SWOT・財務分析
    Valiant Holding AG - Strategy, SWOT and Corporate Finance Report Summary Valiant Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Chemtrade Logistics Income Fund (CHE.UN):企業の財務・戦略的SWOT分析
    Chemtrade Logistics Income Fund (CHE.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Global Orthopaedic Technology Pty Ltd-医療機器分野:企業M&A・提携分析
    Summary Global Orthopaedic Technology Pty Ltd (Global) is an orthopaedic implant designer and manufacturer. The company offers orthopaedic implants for knee, hip and spine. Its hip products include global cup, bioball system, paragon stem, absolut cemented stem, and unisyn hip system among others. I …
  • Korea Line Corp (005880):企業の財務・戦略的SWOT分析
    Summary Korea Line Corp (KLC) is a shipping company that offers tramper carrier services and dedicated carrier services. The company transports liquid natural gas through vessels and provides tramper carrier service related to dry bulk products. It also transports iron ore, grain, coal, liquid oil, …
  • PayPal Holdings Inc:企業の戦略・SWOT・財務分析
    PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary PayPal Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Analytik Jena AG:企業の戦略的SWOT分析
    Analytik Jena AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • IVRCL Ltd:企業の戦略・SWOT・財務情報
    IVRCL Ltd - Strategy, SWOT and Corporate Finance Report Summary IVRCL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Hainan Airlines Co Ltd:企業の戦略・SWOT・財務情報
    Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Hainan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • S Chand And Company Limited (SCHAND):企業の財務・戦略的SWOT分析
    S Chand And Company Limited (SCHAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Baoviet Holdings
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bracket Global LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Bracket Global LLC (Bracket Global) is a clinical research organization that provides clinical technology solution that helps to improve clinical research experience. The organization’s Bracket eCOA is a flexible platform for electronic Clinical Outcomes Assessments that collects data from p …
  • NuvOx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NuvOx Pharma LLC (NuvOx Pharma) is a biotechnology company that develops oxygen therapeutics for the treatment of human diseases. The company develops novel therapies and formulations based on dodecafluoropentane emulsion platform. Its pipeline products include compounds such as NVX-108, NVX …
  • Burgan Bank Sak:企業の戦略・SWOT・財務分析
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Phibro Animal Health Corp (PAHC):企業の財務・戦略的SWOT分析
    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tetra Pak International SA:企業の戦略・SWOT・財務分析
    Tetra Pak International SA - Strategy, SWOT and Corporate Finance Report Summary Tetra Pak International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Thoresen Thai Agencies Public Company Limited:企業の戦略・SWOT・財務情報
    Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Hydro One Ltd (H):電力:M&Aディール及び事業提携情報
    Summary Hydro One Ltd (Hydro One) is a utility holding company that conducts electricity transmission and distribution in Ontario through its subsidiaries. It also undertakes telecommunications business and certain corporate activities. The company serves residential, commercial and industrial custo …
  • Nikon Corporation:企業の戦略・SWOT・財務情報
    Nikon Corporation - Strategy, SWOT and Corporate Finance Report Summary Nikon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Aditya Birla Retail Ltd:企業の戦略的SWOT分析
    Aditya Birla Retail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆